Bayer says it is putting aside more than $4.5 Billion dollars for future lawsuits about Roundup but stresses the product will remain available for farmers.
This spring, a judge rejected Bayer’s plan to limit the cost of settlements in claims that its glyphosate product cause non-Hodgkins lymphoma.
In a call with investors (this morning), Bayer officials say they will file a petition with the U.S. Supreme Court to review the lower court ruling in favor of Roundup user Edwin Hardeman.